GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $608,854,000 | -41.2% | 16,069 | -33.8% | 1.44% | +28.0% |
| Q3 2019 | $1,035,800,000 | +99977.3% | 24,269 | -6.2% | 1.12% | +3.7% |
| Q2 2019 | $1,035,000 | -16.0% | 25,865 | -12.3% | 1.08% | -2.1% |
| Q1 2019 | $1,232,000 | +8.9% | 29,476 | -0.4% | 1.11% | -0.4% |
| Q4 2018 | $1,131,000 | -43.4% | 29,600 | -40.5% | 1.11% | -22.2% |
| Q3 2018 | $1,998,000 | +67.1% | 49,752 | +67.5% | 1.43% | +101.4% |
| Q2 2018 | $1,196,000 | -99.9% | 29,694 | -11.0% | 0.71% | -2.6% |
| Q1 2018 | $1,304,234,000 | -83.3% | 33,382 | -84.9% | 0.73% | -79.6% |
| Q4 2017 | $7,819,361,000 | +253.2% | 220,450 | +304.3% | 3.57% | +267.6% |
| Q3 2017 | $2,213,918,000 | -15.5% | 54,530 | -10.3% | 0.97% | -1.6% |
| Q2 2017 | $2,620,876,000 | -36.7% | 60,781 | -38.1% | 0.99% | -22.8% |
| Q1 2017 | $4,138,172,000 | +73.3% | 98,154 | +77.3% | 1.28% | +26.6% |
| Q3 2016 | $2,387,806,000 | – | 55,363 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |